TITLE

California Embryonic Stem Cell Research Agency Will Issue Bonds

PUB. DATE
June 2007
SOURCE
National Right to Life News;Jun2007, Vol. 34 Issue 6, p7
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article reports on the plan of the California Institute for Regenerative Medicine to issue bonds to fund embryonic stem cell research in the state. The proceeds of the first sale of the bond will be used to repay the loans made by the institute during the lawsuits and to fund more research grants. The 1st District Court of Appeal and state Supreme Court ruled in favor of the program which is opposed by pro-life and taxpayer groups. The reasons behind the opposition to the program are cited.
ACCESSION #
25547238

 

Related Articles

  • The Debate Over: Stem Cells Gets Hot. D'Agnese, Joseph // Discover;Jan2002, Vol. 23 Issue 1, p56 

    Focuses on the controversy over stem cell research in the United States. Advantages in using embryonic stem cells; Funds granted to stem cells research; Sufficiency of embryos in medical treatment. INSETS: NEWS FROM THE WORLD OF ADULT STEM-CELL RESEARCH.;NEWS OF EMBRYONIC STEM CELLS.;A REVERSE...

  • DESIGNING AN EFFECTIVE PROGRAM OF STATE-SPONSORED HUMAN EMBRYONIC STEM CELL RESEARCH. Noll, Roger G. // Berkeley Technology Law Journal;Summer2006, Vol. 21 Issue 3, p1143 

    The article discusses the methods of establishing an effective program of state-sponsored human embryonic stem cell research as depicted in the creation of the California Institute for Regenerative Medicine. One of the methods is the elimination of "pork barrel" effects on the funding for these...

  • FROM THE LAB.  // Medical Technology & Devices Week;2/26/2007, Vol. 5 Issue 9, p1 

    The article reports on the awarding of the Scientific Excellence through Exploration and Development (SEED) Grants to several human embryonic stem cell (hESC) studies in California. The Independent Citizens Oversight Committee (ICOC), governing board of the California Institute for Regenerative...

  • Stem Cell Suicide. Davies, Kevin // Bio-IT World;Jul2003, Vol. 2 Issue 7, p6 

    Offers updates on the state of embryonic stem cell research despite funding restrictions issued by the U.S. government, as of July 2003. Breakthroughs in the field of embryonic stem cell research; Pledge made by National Institutes of Health Director Elias Zerhouni to help improve stem cell...

  • "CIRM Awards $25 Mln To Support Spinal-Cord Injury Trial, $37.7 Mln for Basic Stem-Cell Science".  // Biomedical Market Newsletter;5/9/2011, p143 

    The article reports that the Governing Board of the California Institute for Regenerative Medicine (CIRM), the State Stem Cell Agency, has approved a grant worth 25 million dollars to support the first U.S. Food & Drug Administration (FDA)-approved clinical trial based on cells derived from...

  • California Voters Will Decide Fate Of $3B of GOs for Stem Cell Researcxh. Saskal, Rich // Bond Buyer;6/4/2004, Vol. 348 Issue 31898, p4 

    Reports that Californians will vote in November 2004 on a proposed $3 billion general obligation bond to fund embryonic stem cell research. Key issues of interest; Analysis of pertinent topics and relevant issues; Implications on the bond market and genetic research.

  • Local Scientists Team Up on Stem Cell Research. Webb, Marion // San Diego Business Journal;5/16/2005, Vol. 26 Issue 20, p1 

    The article reports that scientific leaders at four major research institutions in La Jolla, California have planned extensively for the upcoming grant-making process behind the scenes. On May 6, 2005 San Francisco, California beat out San Diego, California to be the headquarters for the...

  • New Jersey Funds Embryonic Stem Cell Research.  // National Right to Life News;Jan2006, Vol. 33 Issue 1, p6 

    The article reports on the grants awarded under the Stem Cell Research Grant Program in New Jersey as of December 2005. Information is provided on studies that involve destructive research on human embryos. Commissioner Richard Goldberg voiced his concerns on destructive research.

  • $2.52 million grant work to use ACTC ACTcellerate technology.  // Medical Device Daily;3/21/2007, Vol. 11 Issue 54, p3 

    The article reports on a grant awarded to scientist Randall Lee to fund pre-clinical studies using human embryonic stem cells (HESC) derived from Advanced Cell Technology's proprietary ACTcellerate technology. The research aims to determine if HESC are safe and effective in animal models for...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics